Advertisement
Screener

SPECTRAL AI, INC. (MDAI) EBITDA

SPECTRAL AI, INC. (MDAI) EBITDA

  • 2026-06-30: Basis Reported; EBITDA (m); Operating income -$4.32M; Depreciation and amortization (m).
  • 2026-03-31: Basis Reported; EBITDA (m); Operating income -$1.97M; Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA (m); Operating income -$3.34M; Depreciation and amortization (m).
  • 2025-06-30: Basis Reported; EBITDA (m); Operating income -$2.12M; Depreciation and amortization (m).

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported(m)-$4.32M(m)(m)(m)(m)-$4.10M*(m)$1.70M(m)$170.00K
2026-03-31Reported(m)-$1.97M(m)(m)(m)(m)-$3.73M(m)$2.00M(m)-$10.00K
2025-09-30Reported(m)-$3.34M(m)(m)(m)(m)-$2.50M*(m)$6.23M*(m)$2.00K
2025-06-30Reported(m)-$2.12M(m)(m)(m)(m)-$3.36M*(m)$1.46M(m)-$19.00K
2025-03-31Reported(m)-$896.00K(m)(m)(m)(m)-$1.50M(m)$3.60M(m)$71.00K
2024-09-30Reported(m)-$886.00K(m)(m)(m)(m)-$1.63M*(m)(m)(m)$37.00K
2024-06-30Reported(m)-$2.44M(m)(m)(m)(m)-$5.36M*(m)(m)(m)$69.00K
2024-03-31Reported(m)-$2.14M(m)(m)(m)(m)-$2.68M(m)$4.30M(m)$22.00K
2023-09-30Reported(m)-$4.17M(m)(m)(m)(m)-$5.34M*(m)(m)(m)-$54.00K
2023-06-30Reported(m)-$2.99M(m)(m)(m)(m)-$1.77M*(m)(m)(m)$40.00K
2023-03-31Reported(m)-$2.90M(m)(m)(m)(m)-$3.75M(m)$4.00M(m)$46.00K
2022-09-30Reported(m)-$251.00K(m)(m)(m)(m)-$901.00K*(m)(m)(m)$85.00K
2022-06-30Reported(m)-$6.00K(m)(m)(m)(m)$341.51K*(m)(m)(m)$11.00K
2022-03-31Reported(m)-$465.12K(m)(m)(m)(m)-$303.51K(m)(m)(m)-$7.52M
2021-09-30Reported(m)-$1.19M(m)(m)(m)(m)-$4.92K*(m)(m)(m)-$3.42M
2021-06-30Reported(m)-$287.04K(m)(m)(m)(m)-$576.35K*(m)(m)(m)(m)
2021-03-31Reported(m)-$157.82K(m)(m)(m)(m)-$149.99K(m)(m)(m)-$3.38M

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported(m)-$8.60M(m)(m)(m)(m)-$9.92M(m)(m)(m)$11.00K
2024-12-31Reported(m)-$6.58M(m)(m)(m)(m)-$9.20M(m)(m)(m)$114.00K
2023-12-31Reported(m)-$12.98M(m)(m)(m)(m)-$13.24M(m)$15.10M(m)$11.00K
2022-12-31Reported(m)-$2.65M(m)(m)(m)(m)-$1.16M(m)$16.50M(m)$106.00K
2021-12-31Reported(m)-$3.42M(m)(m)(m)(m)-$825.59K(m)(m)(m)$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
TELA Bio, Inc. (TELA)United States$0.057B-0.82
NEPHROS INC (NEPH)United States$0.046B23.02
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
DarioHealth Corp. (DRIO)$0.066B-1.39
CVRx, Inc. (CVRX)United States$0.067B-2.62
InspireMD, Inc. (NSPR)$0.033B
PAVmed Inc. (PAVM)United States$0.031B-3.00
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18